Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-053571
Filing Date
2022-04-29
Accepted
2022-04-29 16:16:10
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2212872d2_def14a.htm DEF 14A 364958
2 GRAPHIC tm2212872d2_def14aimg01.jpg GRAPHIC 1529
3 GRAPHIC tm2212872d2_def14aimg02.jpg GRAPHIC 284881
4 GRAPHIC tm2212872d2_def14aimg03.jpg GRAPHIC 197290
  Complete submission text file 0001104659-22-053571.txt   1032725
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 22875666
SIC: 2834 Pharmaceutical Preparations